Enzymatic DNA Synthesis Market is expected to reach US$ 2,244.88 million by 2028

Publisher: The Insight Partners

DNA Library Synthesis Segment to Lead Global Enzymatic DNA Synthesis Market During 2022–2028

According to our new research study on “Enzymatic DNA Synthesis Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product Type, Application, Technology, and End User,” the enzymatic DNA synthesis market is expected to grow from US$ 240.96 million in 2022 to US$ 2,244.88 million by 2028; it is estimated to register a CAGR of 45.1% during 2022–2028. Key factors driving the growth of the market include the rising prevalence of genetic disorders and surging number of product launches.

Based on product type, the enzymatic DNA synthesis market is bifurcated into custom DNA synthesis and DNA library synthesis. The DNA library synthesis segment held the largest share of the market in 2022 and is anticipated to register a CAGR of 44.5% in the market during the forecast period. The market growth of this segment is attributed to the advantages of DNA library synthesis in systematic, unbiased investigations; high-throughput screening for discovery biology, and in-vitro molecular optimization to generate mutant proteins with improved or novel properties.

Enzymatic DNA Synthesis Market, by Region, 2022 (%)

To get free sample copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPRE00027647

Source: The Insight Partners Analysis

Impact of COVID-19 Pandemic on Enzymatic DNA Synthesis Market

The global economy was severely affected due to the COVID-19 pandemic. During the COVID-19 pandemic, hospitals rescheduled or postponed outpatient appointments as far as possible. The impact of the COVID-19 pandemic on the healthcare sector resulted in staffing issues, intraoperative virus transmission risk, procedure prioritization, and changes in perioperative practice. It also led to modifications in the way of working of hospitals and clinics. During this health crisis, enzymatic DNA synthesis methods were used to develop personalized medicines against COVID-19. The growing demand for gene synthesis during this period in the investigation of rapid treatment options against COVID-19 propelled the demand for DNA synthesis. Also, as many R&D facilities were kept closed in 2020, researchers and government authorities focused on developing DNA banks to store genes to be able to continue genetic research work in the post-pandemic period.

Telesis Bio Inc; Evonetix; Ansa Biotechnologies, Inc.; Camena Bio; GenScript Biotech Corp.; Molecular Assemblies; DNA Script; Touchlight; Synbio Technologies; and Twist Bioscience are among the leading companies operating in the enzymatic DNA synthesis market.

Based on product type, the enzymatic DNA synthesis market is segmented into custom DNA synthesis and DNA library synthesis. In terms of application, the market is segmented into synthetic biology, genetic engineering, therapeutic antibodies, vaccine design, and other applications. By end user, the enzymatic DNA synthesis market is divided into academic & research institutes, biotechnology & pharmaceutical companies, diagnostic laboratories, and others. Based on technology, the enzymatic DNA synthesis market is segmented into SOLA, CRISPR, PCR, and others. By geography, the enzymatic DNA synthesis market is segmented into North America (US, Canada, and Mexico), Europe (France, Germany, UK, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and Rest of APAC), the Middle East & Africa (Saudi Arabia, UAE, South Africa, and Rest of MEA), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Contact Us
Contact Us: The Insight Partners 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com